Download free PDF

D-dimer Testing Market Size & Share 2023 to 2032

Market Size by Testing Method (Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays), by Application.

Report ID: GMI5972
   |
Published Date: June 2023
 | 
Report Format: PDF

Download Free PDF

D-dimer Testing Market Size

D-Dimer Testing Market size was valued at over USD 1 billion in 2022 and is projected to reach more than USD 2 billion by 2032. D-dimer testing is a laboratory test used to detect the presence of D-dimer in the blood. D-dimer is a small protein fragment that is produced when a blood clot is dissolved in the body. It is considered a fibrin degradation product.

D-dimer Testing Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 1.2 Billion
  • 2032 Forecast Market Size: USD 1.9 Billion
  • CAGR (2023โ€“2032): 4.3%

Key Market Drivers

  • Growing prevalence of blood clotting related genetic disorders.
  • Technological advancements regarding D-dimer testing.
  • Increasing demand for next-generation point-of-care (POC) D-dimer tests.
  • Government initiatives towards generating awareness regarding blood clotting disorders.

Challenges

  • Lack of trained healthcare professionals.
  • Stringent reimbursement scenario.

Additionally, the growing prevalence of blood clotting related genetic disorders is accelerating market growth. Genetic disorders that increase the risk of blood clot formation are uncommon but can have serious health implications. For instance, protein C and protein S deficiencies are rare, with estimated frequencies of around 1 in 300 to 500 individuals for protein C deficiency and 1 in 20,000 to 25,000 individuals for protein S deficiency.
 

Moreover, increasing demand for next-generation point-of-care (POC) D-dimer tests. POC D-dimer tests enable healthcare providers to immediately rule out or confirm the presence of a thrombotic event, guiding further diagnostic evaluations or treatment plans. Rapid decision-making can lead to more efficient patient management, potentially reducing unnecessary imaging procedures, hospital admissions, and associated costs, thereby augmenting market expansion.

 

COVID-19 Impact

The COVID-19 epidemic had a positive impact on the d-dimer testing market. COVID-19 is associated with an increased risk of blood clotting and thrombotic complications. D-dimer testing plays a crucial role in evaluating and monitoring coagulation abnormalities in COVID-19 patients. As a result, there has been a surge in the utilization of D-dimer testing during the pandemic. COVID-19 can increase the risk of thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). D-dimer testing is instrumental in the diagnosis and management of these complications, assisting in ruling out or confirming the presence of blood clots. Therefore, COVID-19 pandemic accelerated the market growth.
 

D-Dimer Testing Market

D-dimer Testing Market Trends

Technological advancements regarding D-dimer testing are anticipated to stimulate market progression. Immunoassay techniques, such as enzyme-linked immunosorbent assay (ELISA), have been widely used in D-dimer testing. Advances in immunoassay technology have led to the development of overly sensitive and specific assays for detecting D-dimer levels in blood samples. Moreover, integration of D-dimer testing with digital platforms and electronic medical records has facilitated seamless data management, result interpretation, and communication between healthcare professionals. This digitization improves workflow efficiency and enables remote monitoring and consultation.
 

D-dimer Testing Market Analysis

Global D-dimer Testing Market Size, By Testing Method, 2021 - 2032 (USD Billion)

Based on testing method, the d-dimer testing market is segmented into enzyme-linked immunosorbent assay (ELISA), latex-enhanced immuno-turbidimetric assays, fluorescence immunoassays, and others. The enzyme-linked immunosorbent assay (ELISA) segment held the largest revenue size over USD 460 million in 2022 and is estimated to witness significant growth more than USD 700 million by 2032. ELISA assays for D-dimer testing are highly sensitive, capable of detecting even low levels of D-dimer in blood samples. This sensitivity allows for the accurate identification of thrombotic events and helps in ruling out or confirming the presence of blood clots. Furthermore, an increase in the availability of testing method coupled with several other businesses working towards creating innovative technology will support the segment's revenue.
 

Global D-dimer Testing Market Share, By Application, 2022

D-dimer testing market is bifurcated based on the application including deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), others. The deep vein thrombosis (DVT) segment is anticipated to grow over USD 770 million by 2032. DVT is a widespread medical condition that frequently remains untreated and mostly affects hospitalized patients due to immobility. Due to this, DVT is more common, and its accompanying consequences are more likely to occur. In the U.S., venous thrombosis affects more than 200,000 people annually, per research studies. Therefore, increasing prevalence of deep vein thrombosis (DVT) is anticipated to boost d-dimer testing adoption.
 

The d-dimer testing market is segmented by end-use into hospitals, diagnostic centers, research institutes, and others. Diagnostic centers segment held a significant share in the global market accounting for more than 29% business share in 2022 and is estimated to witness significant revenue over USD 600 million by 2032. The diagnostic centers segment is anticipated to hold high growth potential during the analysis period. Due to the widespread availability of innovative and affordable treatments, factors including the increase in laboratory testing and growing preference for diagnostics laboratories will fuel market expansion. These facilities also offer early and precise disease diagnosis and patient treatment, which is anticipated to accelerate segment expansion.
 

U.S. D-dimer Testing Market Size, 2020 -2032 (USD Million)

U.S. d-dimer testing market accounted for more than USD 450 billion in 2022 and will grow momentously more than USD 615 billion by 2032. The affordability of d-dimer testing among the target population base and ongoing technological developments are primarily responsible for the market growth. Further, the region's high healthcare spending on health care management and rising disposable income will spur the North America market forecasts. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S. hence, the potential for market expansion will stimulate over the coming years.
 

D-dimer Testing Market Share

Some of the notable key industry players operating in the d-dimer testing market include :

  • Abbott Laboratories
  • BioMedica Diagnostics
  • biomรฉrieux SA
  • Diazyme Laboratories Inc. (General Atomics)
  • FHoffmann-La Roche Ltd.
  • HORIBA Ltd.
  • Quidel Corporation
  • Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.)
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Unbound Medicine Inc
  • Werfen

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen testing method offerings as well as gain a competitive edge over others.
 

D-dimer Testing Industry News: 

  • In April 2019, in collaboration with Diazyme Laboratories, Inc., Ortho Clinical Diagnostics, a company with headquarters in the U.S., launched their D-Dimer assay. This new test is a part of Ortho Clinical's MicroTip Partnership Assay Programme, which enables the business to offer high-quality, adaptable, rapid, and specialised testing options. This product introduction increased the business's capacity to provide customers with innovative assay.
     

D-dimer testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Testing Method (USD Million)

  • Enzyme-linked immunosorbent assay (ELISA)
  • Latex-enhanced immuno-turbidimetric assays
  • Fluorescence immunoassays
  • Others

By Application (USD Million)

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Disseminated intravascular coagulation (DIC)
  • Others

By End-use (USD Million)

  • Hospitals
  • Diagnostic centers
  • Research institutes
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Poland
    • Switzerland
    • Norway
    • Finland
    • Sweden
    • Denmark
    • The Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Indonesia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Israel

 

Authors:  Monali Tayade, Jignesh Rawal

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • โœ“ Key growth drivers and their assumed impact

    • โœ“ Restraining factors and mitigation scenarios

    • โœ“ Regulatory assumptions and policy change risk

    • โœ“ Technology adoption curve parameter

    • โœ“ Macroeconomic assumptions (GDP growth, inflation, currency)

    • โœ“ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • โœ“ Statistical Validation

    • โœ“ Expert Validation

    • โœ“ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the 2032 estimate for the D-dimer testing market?
The global market for d-dimer testing was over USD 1 billion in 2022 and will reach more than USD 2 billion by 2032.
Why is the ELISA testing method widely used in the D-dimer testing?
The enzyme-linked immunosorbent assay (ELISA) segment will record more than USD 700 million by 2032 as they are highly sensitive and capable of detecting even low levels of D-dimer in blood samples.
What are the factors driving the U.S. d-dimer testing market growth?
The U.S. d-dimer testing industry accounted for more than USD 450 billion in 2022 and will grow to USD 615 billion by 2032 owing to the affordability of d-dimer testing among the target population base and ongoing technological developments.
Which are the top companies in d-dimer testing sector?
Abbott Laboratories, BioMedica Diagnostics, biom
D-dimer Testing Market Scope
  • D-dimer Testing Market Size

  • D-dimer Testing Market Trends

  • D-dimer Testing Market Analysis

  • D-dimer Testing Market Share

Authors:  Monali Tayade, Jignesh Rawal
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 12

Tables & Figures: 279

Countries Covered: 32

Pages: 200

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)